Lindan R
Paraplegia. 1981;19(4):216-9. doi: 10.1038/sc.1981.44.
A total of 234 patients with neuropathic bladder dysfunction and bacteria in the urine have been studied for the presence of antibody coating on the bacteria. Approximately one third of the patients so studied were found to have antibody coated bacteria in the urine (ACB+) by fluorescent microscopy. No correlation could be found between evidence of active tissue infection by the ACB test and the age, sex or catheter status of the patient, the radiological findings or the length of time since the neurological injury. There did, however, appear to be significant differences among the bacterial species isolated, in their ability to invade through urothelium. Testing for antibody coating is a useful epidemiological tool, but is not indicated for routine use as a guide to therapy. The choice of antibacterial drugs can, in most instances, be based on the identification of the bacterial isolate and its known potential for invasion of the upper urinary tract.
对总共234例患有神经源性膀胱功能障碍且尿液中有细菌的患者进行了研究,以检测细菌上是否存在抗体包被。通过荧光显微镜检查发现,在接受此类研究的患者中,约有三分之一的患者尿液中存在抗体包被细菌(ACB+)。通过ACB检测发现的活跃组织感染证据与患者的年龄、性别或导尿管使用情况、放射学检查结果或神经损伤后的时间长短之间未发现相关性。然而,在分离出的细菌种类中,它们穿透尿路上皮的能力似乎存在显著差异。检测抗体包被是一种有用的流行病学工具,但不建议作为治疗指南常规使用。在大多数情况下,抗菌药物的选择可以基于分离出的细菌种类及其已知的侵入上尿路的可能性。